Third Harmonic Bio, Inc. (THRD)
US Market

Third Harmonic Bio, Inc. (THRD) Financial Statements


Third Harmonic Bio, Inc. Financial Overview

Third Harmonic Bio, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.742; its P/E ratio is -18.85; Third Harmonic Bio, Inc. is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -10.40M$ -10.81M$ -10.72M$ -9.09M-
EBITDA$ -10.39M--$ -9.08M-
Net Income Common Stockholders$ -6.84M$ -7.34M$ -7.56M$ -9.09M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 269.07M$ 273.90M$ 278.10M$ 282.20M$ 288.88M
Total Assets$ 277.71M$ 282.25M$ 285.79M$ 291.32M$ 298.68M
Total Debt$ 3.95M$ 4.12M$ 4.28M$ 4.44M$ 4.34M
Net Debt$ -265.12M$ -269.78M$ -273.82M$ -277.76M$ -284.54M
Total Liabilities$ 8.63M$ 9.29M$ 7.81M$ 8.72M$ 9.61M
Stockholders Equity$ 269.08M$ 272.96M$ 278.05M$ 282.65M$ 289.07M
Cash Flow-
Free Cash Flow$ -5.61M--$ -6.67M$ -9.32M
Operating Cash Flow$ -5.61M$ -4.18M-$ -6.67M$ -9.29M
Investing Cash Flow$ -1.00K---$ -36.00K
Financing Cash Flow$ 798.00K$ -57.00K--$ -875.00K
Currency in USD

Third Harmonic Bio, Inc. Earnings and Revenue History

Third Harmonic Bio, Inc. Debt to Assets

Third Harmonic Bio, Inc. Cash Flow

Third Harmonic Bio, Inc. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis